Tilray Archives | Page 6 of 9

Tilray Makes Move Into US Cannabis Market Via Medmen Convertible Notes

It appears that the rumours surrounding Tilray’s (NASDAQ: TLRY) focus on the US cannabis market were true. The firm this

Tilray Inc. (TSX: TLRY) released yesterday morning its full-year financial results for the 2021 fiscal year ending May 31, 2021,

Tilray (TSX: TLRY) (NASDAQ: TLRY) will be reporting its fourth quarter financial results on July 28 before the market opens.

With the Aphria, Tilray (NASDAQ: TLRY) merger finalized and Aphria shares consolidated earlier this month, many analysts are now updating

Earlier this week, Tilray (NASDAQ: TLRY) finalized their merger with Aphria (NASDAQ: APHA) (TSX: APHA), with Aphria shares getting converted

Tilray (NASDAQ: TLRY) and Aphria (TSX: APHA) (NASDAQ: APHA) have formally closed their previously announced merger arrangement. The closing follows

Aphria Inc (TSX: APHA) (NASDAQ: APHA) has seen its shareholders approve the proposed merger with that of Tilray Inc (NASDAQ:

Aphria Inc (TSX: APHA) (NASDAQ: APHA) is evidently looking to drum up shareholder support for its proposed transaction with Tilray

Aphria Inc (TSX: APHA) (NASDAQ: APHA) this evening reported that the transaction with that of Tilray Inc (NASDAQ: TLRY) is